AI Terminal
IMI PLC
Director's Dealing • Mar 13, 2025
5257_dirs_2025-03-13_9c3c2be7-a1f3-431b-a5c5-bd17922c3ef3.html
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 6269A
IMI PLC
13 March 2025
13 March 2025
IMI PLC
(the "Company")
Notification of Transactions by Persons Discharging Managerial Responsibilities ("PDMRs")
IMI plc ("IMI" or the "Company") announces that on 4 March 2025 Jamie Pike, Chair, purchased 4,873 ordinary shares of 28 4/7p each in the Company at a price of £20.535 per share.
This notification relates to transactions notified in accordance with the Market Abuse Regulation, further details below:
| 1. | Details of the person discharging managerial responsibilities/person closely associated | |||
| a) | Name | Jamie Pike | ||
| 2. | Reason for the notification | |||
| a) | Position/status | Non-executive Chair | ||
| b) | Initial notification/ Amendment | Initial Notification | ||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||
| a) | Name | IMI plc | ||
| b) | LEI | 2138002W9Q21PF751R30 | ||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted | |||
| a) | Description of the financial instrument, type of instrument Identification code |
Ordinary shares GB00BGLP8L22 |
||
| b) | Nature of the transaction | Purchase of ordinary shares | ||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |
| £20.535 | 4,873 | |||
| d) | Aggregated information · Aggregated volume · Price |
4,873 £100,067.055 |
||
| e) | Date of the transaction | 4 March 2025 | ||
| f) | Place of the transaction | London Stock Exchange Main Market (XLON) | ||
For further information, please contact:
Fran Burge
Deputy Company Secretary
Telephone: 0121 717 3700
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHSFIFWDEISESD